UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2882) 2882
Book Chapter (168) 168
Dissertation (25) 25
Conference Proceeding (5) 5
Government Document (5) 5
Publication (4) 4
Book / eBook (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2227) 2227
life sciences & biomedicine (2147) 2147
humans (1495) 1495
chimeric antigen receptor (1176) 1176
immunotherapy (1122) 1122
animals (913) 913
oncology (779) 779
antigens (770) 770
t cells (697) 697
immunology (646) 646
t-lymphocytes - immunology (584) 584
cancer (569) 569
lymphocytes (530) 530
mice (521) 521
lymphocytes t (481) 481
immunotherapy, adoptive - methods (426) 426
hematology (411) 411
medicine, research & experimental (410) 410
research & experimental medicine (410) 410
leukemia (341) 341
tumors (334) 334
biotechnology & applied microbiology (325) 325
care and treatment (321) 321
neoplasms - therapy (315) 315
receptors, antigen, t-cell - genetics (296) 296
receptors, antigen, t-cell - immunology (278) 278
neoplasms - immunology (265) 265
female (263) 263
cell line, tumor (259) 259
review (259) 259
research (256) 256
cytokines (250) 250
immunotherapy, adoptive (246) 246
t-lymphocytes - metabolism (231) 231
health aspects (229) 229
cytotoxicity (228) 228
cell biology (224) 224
clinical trials (221) 221
biochemistry & molecular biology (215) 215
recombinant fusion proteins - genetics (211) 211
lymphoma (210) 210
receptors, antigen, t-cell - metabolism (209) 209
t-lymphocytes - transplantation (206) 206
genetic engineering (202) 202
chimeric antigen receptors (196) 196
receptors, chimeric antigen - immunology (194) 194
recombinant fusion proteins - immunology (186) 186
proteins (180) 180
gene therapy (179) 179
t cell receptors (179) 179
male (175) 175
patients (172) 172
genetics & heredity (169) 169
receptors, chimeric antigen - genetics (169) 169
receptors, chimeric antigen - metabolism (168) 168
receptors (159) 159
gene expression (157) 157
antibodies (156) 156
immunotherapy - methods (154) 154
antigens, neoplasm - immunology (153) 153
adoptive immunotherapy (152) 152
chemotherapy (152) 152
cancer therapies (151) 151
chimeric antigen receptor t cells (150) 150
stem cells (149) 149
cancer immunotherapy (146) 146
cell line (140) 140
flow cytometry (140) 140
treatment outcome (138) 138
monoclonal antibodies (137) 137
xenograft model antitumor assays (137) 137
cd19 antigen (134) 134
adoptive cell therapy (133) 133
solid tumors (133) 133
antigens, cd19 - immunology (132) 132
lymphocytes b (131) 131
cytokine release syndrome (130) 130
toxicity (130) 130
neoplasms. tumors. oncology. including cancer and carcinogens (126) 126
medical research (125) 125
immunotherapy, adoptive - adverse effects (119) 119
pharmacology & pharmacy (118) 118
transplantation (118) 118
cd19 (117) 117
signal transduction (116) 116
immune system (114) 114
cell proliferation (113) 113
recombinant fusion proteins - metabolism (112) 112
acute lymphoblastic leukemia (111) 111
cytotoxicity, immunologic (109) 109
adoptive transfer (107) 107
genetic aspects (107) 107
natural killer cells (107) 107
t cell (107) 107
clinical trials as topic (106) 106
multiple myeloma (106) 106
disease models, animal (104) 104
apoptosis (101) 101
receptors, chimeric antigen (100) 100
usage (100) 100
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3032) 3032
Japanese (21) 21
Chinese (16) 16
Russian (14) 14
French (13) 13
German (11) 11
Norwegian (4) 4
Czech (3) 3
Portuguese (3) 3
Korean (2) 2
Spanish (2) 2
Swedish (2) 2
Croatian (1) 1
Danish (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncoimmunology, ISSN 2162-402X, 10/2014, Volume 1, Issue 4, pp. 458 - 466
Adoptive therapy with chimeric antigen receptor (CAR) redirected T cells recently showed remarkable anti-tumor efficacy in early phase clinical trials... 
OX40 | CD28 | chimeric antigen receptor | adoptive cell therapy | IL-10 | Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Chimeric antigen receptor | Adoptive cell therapy | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Research Paper
Journal Article
2019, ISBN 9780128195734, 94
Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents the latest on how T cell adoptive immunotherapy has progressed in its ultimate goal of curing metastatic malignant cancers... 
Cancer-Treatment | Immunotherapy | Genetic engineering | T cells | Cancer
eBook
Journal Article
The oncologist (Dayton, Ohio), ISSN 1549-490X, 04/2018, Volume 23, Issue 8, pp. 943 - 947
...., South San Francisco, CA) for the treatment of severe or life‐threatening chimeric antigen receptor (CAR) T cell... 
Cytokine release syndrome | Chimeric antigen receptor | Interleukin‐6 | Tocilizumab | T cell | Immunotherapy | Interleukin-6 | Life Sciences & Biomedicine | Oncology | Science & Technology | FDA | Regulatory Issues
Journal Article
Molecular therapy, ISSN 1525-0016, 09/2017, Volume 25, Issue 9, pp. 2189 - 2201
We explored the utility of targeting anaplastic lymphoma kinase (ALK), a cell surface receptor overexpressed on pediatric solid tumors, using chimeric antigen receptor (CAR... 
ALK | tumor immunology | CAR | antigen density | anaplastic lymphoma kinase | immunotherapy | neuroblastoma | chimeric antigen receptor | Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Neoplasms - metabolism | Humans | Recombinant Fusion Proteins | Lymphocyte Activation - immunology | Neoplasms - therapy | Neoplasms - genetics | T-Lymphocytes - metabolism | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Lentivirus - genetics | Gene Order | Disease Models, Animal | Antigens, Neoplasm - genetics | Gene Expression | Immunotherapy, Adoptive | Receptors, Antigen, T-Cell - metabolism | Antigens, Neoplasm - immunology | Receptors, Cell Surface - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Genetic Vectors - genetics | Xenograft Model Antitumor Assays | Animals | Receptor Protein-Tyrosine Kinases - genetics | Neoplasms - immunology | Cell Line, Tumor | T-Lymphocytes - immunology | Mice | Receptors, Antigen, T-Cell - genetics | Flow cytometry | Pediatrics | Leukemia | Lymphocytes T | Neuroblastoma | Kinases | Cell surface | AACR | Cell activation | Lymphocytes | Immunotherapy | Xenografts | Tumor necrosis factor-TNF | Protein-tyrosine kinase | Medical research | Antigens | Cytokines | Cyclin-dependent kinases | Lymphoma | Medical prognosis | Internalization | γ-Interferon | Monoclonal antibodies | Mutation | Solid tumors | Cancer | Tumors | Index Medicus | Original
Journal Article
Human gene therapy, ISSN 1557-7422, 05/2018, Volume 29, Issue 5, pp. 585 - 601
.... To target BCMA using redirected autologous T cells, lentiviral vectors (LVV) encoding chimeric antigen receptors (CARs... 
Research Articles | gene therapy | multiple myeloma | BCMA | CAR | adoptive cell therapy | immunotherapy | Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Hematologic Neoplasms - therapy | Humans | Hematologic Neoplasms - pathology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Multiple Myeloma - therapy | CD3 Complex - genetics | T-Lymphocytes - drug effects | Lentivirus - genetics | Gene Expression Regulation, Neoplastic - drug effects | Cytotoxicity, Immunologic - drug effects | B-Cell Maturation Antigen - antagonists & inhibitors | B-Cell Maturation Antigen - immunology | Immunotherapy, Adoptive | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Xenograft Model Antitumor Assays | Receptors, Chimeric Antigen - therapeutic use | Multiple Myeloma - pathology | Animals | Receptors, Chimeric Antigen - immunology | CD3 Complex - immunology | Cell Line, Tumor | T-Lymphocytes - immunology | Hematologic Neoplasms - genetics | Mice | Hematologic Neoplasms - immunology | Multiple Myeloma - genetics | Biotechnology | Animal models | Intravenous administration | Leukemia | Multiple myeloma | Lymphocytes T | Receptors | Lymphocytes | Peripheral blood | Antigens | Chronic lymphatic leukemia | CD137 antigen | Hematology | Maturation | Tumor cells | Therapeutic applications | Pharmacology | Tumor cell lines | Lymphatic leukemia | Lymphoma | Molecular chains | Burkitt's lymphoma | Lymphocytes B | Mantle cell lymphoma | Plasma cells | Tumors | Index Medicus
Journal Article
Cancer discovery, ISSN 2159-8290, 04/2016, Volume 6, Issue 6, pp. 664 - 679
Journal Article